Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
575.23B
Market cap575.23B
Price-Earnings ratio
21.87
Price-Earnings ratio21.87
Dividend yield
2.15%
Dividend yield2.15%
Average volume
6.64M
Average volume6.64M
High today
$242.30
High today$242.30
Low today
$238.59
Low today$238.59
Open price
$241.55
Open price$241.55
Volume
1.13M
Volume1.13M
52 Week high
$251.71
52 Week high$251.71
52 Week low
$145.13
52 Week low$145.13

Stock Snapshot

With a market cap of 575.23B, Johnson & Johnson(JNJ) trades at $238.82. The stock has a price-to-earnings ratio of 21.87 and currently yields dividends of 2.2%.

On 2026-04-10, Johnson & Johnson(JNJ) stock traded between a low of $238.59 and a high of $242.30. Shares are currently priced at $238.82, which is +0.1% above the low and -1.4% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 1.13M, against a daily average of 6.64M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $145.13.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $145.13.

JNJ News

Nasdaq 14h
Could Buying This Dividend Pharma Stock Today Set You Up for Life?

Key Points Johnson & Johnson has an incredible dividend-increase streak spanning more than 60 years. The company's business is diversified beyond drugs, provi...

Could Buying This Dividend Pharma Stock Today Set You Up for Life?
Simply Wall St 15h
Is It Time To Reassess Johnson & Johnson After Its Strong 1-Year Share Price Run?

If you are wondering whether Johnson & Johnson at around US$241 a share is still reasonably priced or already stretched, the next sections will walk through wha...

Is It Time To Reassess Johnson & Johnson After Its Strong 1-Year Share Price Run?
Benzinga 1d
Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Johnson & Johnson (NYSE:JNJ) will release earnings for its first quarter before the opening bell on Tuesday, April 14. Analysts expect the New Brunswick, New J...

Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Analyst ratings

59%

of 29 ratings
Buy
58.6%
Hold
34.5%
Sell
6.9%

More JNJ News

Simply Wall St 2d
Assessing Royalty Pharma Valuation After Johnson & Johnson Autoimmune Co Funding Deal

Advertisement Royalty Pharma (RPRX) is back in focus after announcing a US$500 million R&D co funding agreement with Johnson & Johnson to advance JNJ-4804, an...

Assessing Royalty Pharma Valuation After Johnson & Johnson Autoimmune Co Funding Deal
TipRanks 2d
Johnson & Johnson assumed with a Buy at TD Cowen

TD Cowen assumed coverage of Johnson & Johnson with a Buy rating and $250 price target The firm sees the company’s “strong” product portfolio driving 7% annual...

Simply Wall St 2d
Johnson And Johnson PFA Launch In Europe Puts MedTech In Focus

Johnson & Johnson (NYSE:JNJ) has launched its VARIPULSE Pro pulsed field ablation system in Europe for cardiac arrhythmia procedures. The European rollout intr...

Johnson And Johnson PFA Launch In Europe Puts MedTech In Focus
Investor's Business Daily 3d
Dow Jones Medical Giant Johnson & Johnson Eyes Latest Buy Point

Stocks Near A Buy Zone Dow Jones Medical Giant Johnson & Johnson Eyes Latest Buy Point Licensing As the Dow Jones Industrial Average and other stock indexes tra...

Dow Jones Medical Giant Johnson & Johnson Eyes Latest Buy Point
TipRanks 3d
Johnson & Johnson announces launch of Varipulse Pro in Europe

Johnson & Johnson announced the launch of Varipulse Pro in Europe following CE Mark approval, further advancing its pulsed field ablation portfolio. This new pu...

The Motley Fool 3d
You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500.

The first quarter was a difficult one for the S&P 500 and for investors as a variety of concerns circulated -- from worries about the revenue potential of artif...

You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500.
24/7 Wall St. 4d
$10,000 to Invest? Coca-Cola or Johnson & Johnson- One Stock Is More Reliable

$10,000 to Invest? Coca-Cola or Johnson & Johnson- One Stock Is More Reliable By Vandita Jadeja Published Apr 6, 12:15PM EDT Quick Read Johnson & Johnson (JNJ...

$10,000 to Invest? Coca-Cola or Johnson & Johnson- One Stock Is More Reliable

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.